TEAD2 was shown to act cooperatively with the E2F transcription factor to promote a cell-cycle gene expression program, which enabled the bypass of oncogenic KRAS addiction in PDAC and evoked KRAS-independent tumor relapse [171]. Here, KRAS is linked to neoplasm.